Effect of Prematurity on Renal Function in 5 Years Old Children
NCT00817921 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 168
Last updated 2014-02-05
Summary
Purpose of the study:
1. To evaluate the effect of prematurity on renal function in 5 years old children
2. To compare former premature children treated by ibuprofen in the neonatal period to controls
Conditions
- Prematurity of Fetus
Sponsors & Collaborators
-
Jean Michel Hascoet
lead OTHER
Principal Investigators
-
Jean-Michel HASCOET, MD · Maternite Regionale Universitaire
Eligibility
- Min Age
- 3 Years
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-11-30
- Primary Completion
- 2012-12-31
- Completion
- 2013-12-31
Countries
- France
Study Locations
More Related Trials
-
High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm Infant
NCT01243996 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Registration and Treatment of Pain During Eye Examination of Prematurity
NCT01552993 ·Status: TERMINATED ·Phase: NA
-
PDA Treatment With Ibuprofen and Changes in Tissue Oxygenation.
NCT05325177 ·Status: RECRUITING ·Phase: PHASE4
-
Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.
NCT02056223 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Pain Management During Screening for Retinopathy of Prematurity
NCT04767178 ·Status: COMPLETED
-
Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus
NCT03701074 ·Status: TERMINATED ·Phase: PHASE2
-
Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
NCT00642330 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants
NCT01149564 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Relation Between Prostaglandin E2 Metabolite Levels and the Development of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates
NCT07338370 ·Status: RECRUITING
-
Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants
NCT05340582 ·Status: RECRUITING ·Phase: PHASE2
-
Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants
NCT02079298 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)
NCT01511887 ·Status: COMPLETED ·Phase: NA
-
Paracetamol Versus Ibuprofen for PDA Closure
NCT03265782 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants
NCT01261117 ·Status: COMPLETED ·Phase: NA
-
Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department
NCT07074912 ·Status: RECRUITING ·Phase: NA
-
Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen
NCT04459117 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Paracetamol in Patent Ductus Arteriosus
NCT02422966 ·Status: COMPLETED ·Phase: PHASE2
-
Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT
NCT07143201 ·Status: RECRUITING ·Phase: PHASE2
-
Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies
NCT00470743 ·Status: WITHDRAWN ·Phase: PHASE4
-
Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants
NCT01544972 ·Status: UNKNOWN ·Phase: PHASE4
-
Randomized Trial of NSAID vs Placebo Prior to Ureteral Stent Removal
NCT02140970 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA
NCT00440804 ·Status: COMPLETED ·Phase: PHASE3
-
Population Pharmacokinetics and Dosage Individualization of Paracetamol and Ibuprofen in Children With PDA
NCT04397913 ·Status: UNKNOWN
-
Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients
NCT02583399 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Evaluate Two Guidelines for the Administration of Ibuprofen in the Treatment of Persistent Ductus Arteriosus Eco-guided: Impact in the Intestinal Prognosis
NCT04282941 ·Status: UNKNOWN ·Phase: PHASE3